Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Raw Materials (2020 - 2026)

NeuroPace has reported Raw Materials over the past 7 years, most recently at $6.1 million for Q1 2026.

  • For Q1 2026, Raw Materials rose 44.92% year-over-year to $6.1 million; the TTM value through Mar 2026 reached $6.1 million, up 44.92%, while the annual FY2025 figure was $6.2 million, 60.36% up from the prior year.
  • Raw Materials for Q1 2026 was $6.1 million at NeuroPace, down from $6.2 million in the prior quarter.
  • Over five years, Raw Materials peaked at $6.4 million in Q3 2025 and troughed at $2.3 million in Q1 2022.
  • A 5-year average of $4.2 million and a median of $3.9 million in 2024 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: skyrocketed 99.17% in 2023 and later fell 16.0% in 2024.
  • Year by year, Raw Materials stood at $2.8 million in 2022, then skyrocketed by 45.14% to $4.1 million in 2023, then decreased by 5.33% to $3.9 million in 2024, then skyrocketed by 60.36% to $6.2 million in 2025, then fell by 1.53% to $6.1 million in 2026.
  • Business Quant data shows Raw Materials for NPCE at $6.1 million in Q1 2026, $6.2 million in Q4 2025, and $6.4 million in Q3 2025.